ARWR — Arrowhead Pharmaceuticals, Inc. stock price, charts and financials

QT66Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
89.59
+3.58+4.16%
OverviewShort InterestFilings
ARWRQT66Arrowhead Pharmaceuticals, Inc.·NASDAQ
89.59+4.16%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 202610-QQuarterly report
Aug 04, 20268-KCurrent report
Jul 31, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20263Initial statement of beneficial ownership
Jun 16, 20268-KCurrent report
May 14, 20264Statement of changes in beneficial ownership
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
May 07, 2026S-8Registration of employee benefit securities
May 06, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 28, 2026SC 13GBeneficial ownership statement (passive)
Apr 24, 20264Statement of changes in beneficial ownership
Apr 24, 20264Statement of changes in beneficial ownership
Apr 24, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 20, 20268-KCurrent report
Mar 09, 20264Statement of changes in beneficial ownership
Feb 05, 202610-QQuarterly report
Feb 05, 20268-KCurrent report
Jan 27, 2026DEF 14ADefinitive proxy statement
Jan 27, 2026DEFA14AAdditional proxy soliciting materials
Jan 27, 2026ARSAnnual report to shareholders
#1 / 25 of 288
Page
▼
/ 12